The 2024 Pomegranate Industry Development Conference held in Zaozhuang City, Shandong Province -- Pomegranate Industry Shows New Vitality
September 26, 2024 05:23 ET
|
Cyberspace Affairs Office of the CPC Zaozhuang Municipal Committee
ZAOZHUANG, China, Sept. 26, 2024 (GLOBE NEWSWIRE) -- According to the Cyberspace Affairs Office of the CPC Zaozhuang Municipal Committee, the 2024 Pomegranate Industry Development Conference was...
Kronos Bio to Present Data at ACR Convergence 2024 to Support p300 KAT Inhibition as an Approach to Anti-Inflammatory Therapy
September 25, 2024 08:55 ET
|
Kronos Bio, Inc.
– Through selective inhibition of proinflammatory transcription, p300 KAT inhibition modulates the activity and function of multiple pro-inflammatory signaling pathways that drive chronic inflammatory...
Chronic Kidney Disease (CKD) Drugs Market is projected to reach USD 23.8 Billion, garnering a 4.2% CAGR from 2024 to 2034: Transparency Market Research, Inc.
September 24, 2024 08:32 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Transparency Market Research Inc. -, Sept. 24, 2024 (GLOBE NEWSWIRE) -- The global chronic kidney disease (CKD) drugs market (만성신장질환(CKD) 치료제 시장) was projected...
Mabylon AG Receives Research Grants Totaling More Than CHF 1.3 Million for Amyotrophic Lateral Sclerosis (ALS) and Inflammasome Programs
September 24, 2024 04:00 ET
|
AKAMPION
Schlieren, Zurich/Switzerland, September 24, 2024 - Mabylon AG, a leader in the high-throughput discovery, characterization, and development of human-derived antibodies, today announced that it has...
Kronos Bio Highlights Data at AACR Ovarian Cancer Research Symposium that Supports Clinical Evaluation of Istisociclib in Advanced Ovarian Cancer
September 23, 2024 08:55 ET
|
Kronos Bio, Inc.
– New data show istisociclib (KB-0742) triggered cell death in preclinical ovarian cancer models of platinum and PARP-inhibitor (PARPi) resistance – – New PK/PD results demonstrate that istisociclib...
Alterity Therapeutics to Deliver Multiple Oral and Poster Presentations at the International Congress of Parkinson’s Disease and Movement Disorders®
September 23, 2024 07:35 ET
|
ALTERITY THERAPEUTICS LIMITED
- Late Breaking Abstract and Oral Presentation on ATH434-202 Interim Phase 2 Data - - Oral Presentation on ATH434-201 Phase 2 Baseline Characteristics - MELBOURNE, Australia and SAN FRANCISCO, Sept....
Automotive HUD Market Size To Reach USD 5.88 Bn by 2032, Driven by Rising Demand for Safety and Advanced Driver Assistance Systems | Report by SNS Insider
September 19, 2024 06:51 ET
|
SNS Insider pvt ltd
Austin, Sept. 19, 2024 (GLOBE NEWSWIRE) -- The Automotive HUD Market Share is expected to reach USD 5.88 billion by the end of 2032, with a CAGR of around 16.72% during the forecast period of...
Historic First Win: House Passes DeOndra Dixon INCLUDE Project Act
September 18, 2024 10:00 ET
|
Global Down Syndrome Foundation
Denver, Sept. 18, 2024 (GLOBE NEWSWIRE) -- The Global Down Syndrome Foundation (GLOBAL) is proud to announce that the game-changing DeOndra Dixon INCLUDE Project Act (H.R. 7406) passed the U.S....
Engrail Therapeutics Initiates ENX-104 Clinical Program for the Treatment of Major Depressive Disorder Characterized by Anhedonia
September 18, 2024 07:00 ET
|
Engrail Therapeutics, Inc.
Engrail Therapeutics Initiates ENX-104 Clinical Program for the Treatment of Major Depressive Disorder Characterized by Anhedonia
Mini Data Centers Business Research Report 2023-2030: The Concept of Modularity to Help Move Micro Data Centers to the Edge at Faster Time-to-Market Velocity
September 18, 2024 05:33 ET
|
Research and Markets
Dublin, Sept. 18, 2024 (GLOBE NEWSWIRE) -- The "Mini Data Centers - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Mini Data...